Ellume COVID-19 Home Test: Potential for False Positive Results - Healthy Food Deals

Read the Safety Communication to learn about recommendations for test users, caregivers, health care personnel, and the public.

If your email program has trouble displaying this email, view as a webpage. Potential for False Positive Results with Certain Lots of Ellume COVID-19 Home Tests Due to a Manufacturing Issue - FDA Safety Communication Today, the U.S. Food and Drug Administration (FDA) issued a safety communication to alert test users, caregivers, health care personnel, and the public of the potential for false positive results with certain lots of the Ellume COVID-19 Home Test due to a recently identified manufacturing issue. A "false positive" is a test result that says a person has the virus when they do not actually have it. Negative test results do not appear to be affected by the manufacturing issue.    The FDA is not aware of any confirmed serious injuries or deaths related to the false positive results with the affected Ellume COVID-19 Home Tests at this time.   The FDA is working with Ellume to assess Ellume's additional manufacturing checks and other corrective steps to address the reason for the manufacturing issue and help ensure that the issue is resolved.  Read More This safety communication provides:  Recommendations for test users, caregivers, health care personnel, and the public who use the Ellume COVID-19 Home Test.  A summary of the FDA's actions to address the issue.  Instructions for reporting problems with the Ellume COVID-19 Home Test to the FDA.  Questions?  If you have questions about this safety communication, contact the Division of Industry and Consumer Education (DICE).

Follow us on Twitter at @FDADeviceInfo Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA